Fundraising Fox

Relay

4 known investors

Relay Therapeutics develops the Dynamo platform, which applies motion-based drug design principles to discover therapeutic drugs by integrating protein dynamics simulations with experimental and computational techniques. The platform serves pharmaceutical and biotech researchers seeking to accelerate drug discovery across multiple phases of development.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

SK
Sanjiv K. Patel
DB
Don Bergstrom
TC
Tom Catinazzo
MP
Mahesh Padval
IP
Imogen Pryce
PR
Peter Rahmer
PW
Pat Walters
JW
Jim Watters
EK
Eunice Kwak
SL
Soo-Yeun Lim

Investors · 4

EcoR1 CapitalSan Francisco
Nextech InvestZurich · $648K – $3.2M
SoftBank Vision FundLondon
General CatalystreportedSan Francisco · $30M

In the news

H.C. Wainwright raises Relay Therapeutics price target to $29 By Investing.comng.investing.com · Aug 2026Marshall County Relay For Life Raises Nearly $50K For American Cancer Society - The Intelligencertheintelligencer.net · Aug 2026Relay Financial Raises $50M Round to 'Ignite' Brand, Expand Market Reach | Fintech.cafintech.ca · May 2026Relay Secures $50 Million in Financing to Build the Small Business Financial Command Centerfinance.yahoo.com · May 2026Relay Raises $50M in Fundingfinsmes.com · May 2026

Frequently asked questions

What does Relay do?
Relay Therapeutics develops the Dynamo platform, which applies motion-based drug design principles to discover therapeutic drugs by integrating protein dynamics simulations with experimental and computational techniques. The platform serves pharmaceutical and biotech researchers seeking to accelerate drug discovery across multiple phases of development.
Who are Relay's investors?
Relay's investors include EcoR1 Capital, Nextech Invest, SoftBank Vision Fund, General Catalyst.